Edition:
United Kingdom

People: Cerus Corp (CERS.OQ)

CERS.OQ on NASDAQ Stock Exchange Global Market

5.28USD
17 Sep 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$5.28
Open
$5.36
Day's High
$5.41
Day's Low
$5.21
Volume
228,074
Avg. Vol
289,878
52-wk High
$7.54
52-wk Low
$4.49

Moore, Carol 

Ms. Carol M. Moore is Senior Vice President - Regulatory Affairs, Quality and Clinical of Cerus Corp. Ms. Moore was promoted to Senior Vice President, Regulatory Affairs, Quality and Clinical in February 2013. From April 2008 to February 2013, Ms. Moore was our Vice President, Regulatory Affairs, Quality and Clinical. Prior to joining Cerus, Ms. Moore served in various roles at Bayer Corporation, most recently as Vice President, Worldwide Regulatory Affairs, for over 30 years focusing on the registration and regulatory compliance of Bayer’s biological and biotech products, health policy, and strategic planning. Ms. Moore received her BS in Biological Science from California State University, Hayward.

Basic Compensation

Total Annual Compensation, USD 489,804
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 491,940
Fiscal Year Total, USD 981,744

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Daniel Swisher

252,996

William Greenman

2,983,440

Kevin Green

1,022,270

Carol Moore

981,744

William Moore

--

Laurence Corash

1,040,260
As Of  31 Dec 2018